| 摘要 |
The invention provides a proliferation antagonisitic inhibitor of mesenchymal cells, which contains AP-1 nucleotide comprising TGAGTCA or TGACTCA constituting a gene expression promoter, as a therapeutic agent of collagen diseases including rheumatoid arthritis.
|
